
Danaher Corporation DHR
€ 166.82
2.83%
Geschäftsbericht 2025
hinzugefügt 24.02.2026
Danaher Corporation ROE 2011-2026 | DHR
ROE Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.88 | 7.87 | 8.91 | 14.39 | 14.24 | 9.17 | 9.93 | 9.39 | 9.45 | 11.07 | 14.13 | 11.08 | 12.0 | 12.54 | 12.8 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.39 | 6.88 | 10.92 |
ROE Vierteljährlich Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.95 | 5.64 | 9.25 | 10.93 | 9.99 | 12.66 | 13.23 | 10.61 | 12.83 | 12.38 | 10.54 | 6.05 | 10.2 | 10.18 | 10.27 | 9.87 | 8.37 | 8.52 | 8.49 | 9.4 | 10.0 | 9.82 | 9.54 | 9.45 | 9.45 | 8.98 | 9.72 | 11.1 | 10.76 | 14.98 | 15.06 | 14.17 | 14.1 | 11.08 | 11.04 | 11.11 | 11.81 | 11.57 | 11.43 | 12.04 | 11.83 | 12.05 | 12.45 | 12.58 | 12.64 | 12.85 | 13.53 | 12.85 | 3.1 | 3.84 | 2.54 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.06 | 2.54 | 10.45 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-170.35 | - | -6.23 % | $ 30.6 M | ||
|
Agilent Technologies
A
|
22.45 | $ 117.17 | 1.83 % | $ 35.6 B | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 2.2 | -4.35 % | $ 9.73 M | ||
|
Aspira Women's Health
AWH
|
184.36 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1734.41 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-7.05 | $ 16.67 | 3.86 % | $ 888 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Myriad Genetics
MYGN
|
-99.43 | $ 4.6 | 5.63 % | $ 426 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
NeoGenomics
NEO
|
-12.91 | $ 7.96 | 3.51 % | $ 1.02 B | ||
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-227.33 | $ 1.43 | 4.38 % | $ 1.9 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.66 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
65.62 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
4.0 | $ 23.38 | 1.08 % | $ 649 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-43.4 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-181.33 | - | 0.12 % | $ 80.1 M | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 177.66 | 1.14 % | $ 8.81 B | ||
|
Senseonics Holdings
SENS
|
-113.21 | $ 6.69 | 0.15 % | $ 279 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
Medpace Holdings
MEDP
|
98.27 | $ 497.88 | 0.88 % | $ 14.4 B | ||
|
Neuronetics
STIM
|
-174.27 | $ 1.37 | 1.11 % | $ 90.4 M | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
Illumina
ILMN
|
-51.54 | $ 125.77 | 4.0 % | $ 20 B | ||
|
Thermo Fisher Scientific
TMO
|
12.55 | $ 511.92 | 3.14 % | $ 193 B | ||
|
Fulgent Genetics
FLGT
|
-3.77 | $ 15.3 | 5.99 % | $ 463 M | ||
|
Trinity Biotech plc
TRIB
|
287.88 | $ 0.71 | -0.74 % | $ 61.9 M | ||
|
Guardant Health
GH
|
419.18 | $ 81.33 | 3.47 % | $ 10.2 B | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-72.07 | $ 2.79 | 3.72 % | $ 90.5 K | ||
|
Twist Bioscience Corporation
TWST
|
-16.42 | $ 50.08 | 4.52 % | $ 3 B | ||
|
Biomerica
BMRA
|
-121.14 | $ 2.09 | -1.88 % | $ 4.8 M | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
9.97 | $ 28.56 | 0.88 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
8.31 | $ 110.47 | 3.43 % | $ 9.11 B | ||
|
Soleno Therapeutics
SLNO
|
4.64 | $ 52.66 | 0.05 % | $ 2.68 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 264.01 | 1.18 % | $ 22 B | ||
|
Natera
NTRA
|
-77.62 | $ 201.61 | 4.44 % | $ 19.8 B | ||
|
Celcuity
CELC
|
-176.06 | $ 119.02 | 1.6 % | $ 5.57 B | ||
|
Lantheus Holdings
LNTH
|
21.43 | $ 81.19 | 0.74 % | $ 5.48 B | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Waters Corporation
WAT
|
25.09 | $ 322.55 | 0.75 % | $ 19.2 B | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 191.19 | -0.17 % | $ 21.2 B |